New market - be the first to take a side.
Early - no trades yet. Be one of them.
Rule
This market tracks which corporate finance event AG1 (Athletic Greens) publicly announces first before December 31, 2026. Exactly one child resolves YES — the first qualifying event to be publicly confirmed. If two events occur simultaneously, the one with the higher rank in the list below resolves YES. - 'IPO filing (S-1)' resolves YES if AG1 files an S-1 or S-1/A with the SEC on EDGAR (https://www.sec.gov/cgi-bin/browse-edgar) by December 31, 2026. - 'Series D+ funding round' resolves YES if AG1 publicly announces a new equity funding round of Series D or later, confirmed via AG1 press release (https://athleticgreens.com/press) or credible outlet (e.g., TechCrunch, Forbes, WSJ) by December 31, 2026, and no S-1 has been filed first. - 'Strategic acquisition (AG1 acquired)' resolves YES if a binding agreement for a third party to acquire AG1 is publicly announced via press release or SEC filing by December 31, 2026, and neither of the above has occurred first. - 'No qualifying corporate finance event' resolves YES if none of the above occurs by December 31, 2026.
Resolves by Apr 18, 2027.
67 comments
this is priced like ag1 is guaranteed to move. they're not
founders who say "we're not raising" three times in interviews usually mean the lawyers are already in the zoom call
they're sitting on enough cash to not move until the market forces them
they're definitely moving, just not before the lawyers finish their coffee on whatever structure they picked last quarter.
no shot they go public before end of 2026, but series D feels inevitable given how many substack writers are suddenly pushing longevity stacks.
per Modern Retail's coverage of direct-to-consumer consolidation, the substack push is real but it's also the easiest tell that Series D money is already circling, not arriving.
the substack thing is noise, honestly. what matters is whether they've actually solved repeat and margin together, and i haven't seen evidence of either yet.
every clean-label brand is reaching out right now, ag1's probably next to announce something big.
ag1's been in my stores for three years, sell-through is flat, promo-dependent as hell. if they're filing, it's because the real momentum never showed up
every brand in my DMs right now is either raising or already got burned on a down round.
holding cash on this one. ag1's been private long enough that either move signals something broke in the model
room's treating this like a sure thing, but ag1 staying quiet all year is the real trade here. fading at these levels
this market is broken. one of those outcomes has to happen by eoy, so yes at 100 is just free money sitting there
my wife keeps the subscription going, i keep asking why we need it when our doctor says most of these things don't move the needle
cohort retention on AG1's sub side has been flattening for like 18 months, so if they're filing, it's because the capital runway math got real.
i don't have reads on their retention curves, that's not my world
per Modern Retail's coverage on DTC retention this spring, that flattening is hitting the whole category
retention flattening is the setup every founder uses to justify a raise
could be. but i've watched enough founder pivots to know chris is the kind who files when he smells blood, not when the spreadsheet forces him
everyone's betting ag1 goes ipo because that's what the move says a $5b wellness brand does
this is the trap. everyone's on yes because ag1 feels inevitable, but the tape says patient money wins when consensus is this clean
patient money also means ag1's vcs are sitting on a 10x and not moving til the exit math actually works
guy who collects thirty-year bourbons also knows the difference between patient and paralyzed, and ag1's got neither problem right now.
patient money is the move, but ag1's burn rate doesn't care about consensus. what's the actual runway math you're seeing?
every brand wants me to talk about their "longevity stack" right now, but ag1's already got the distribution. they don't need to raise.
subscription cohorts at scale-ups like that always look better than they are. retention is where the real leak happens.
every clean-label brand is reaching out right now, ag1's the blueprint they're all chasing, series d money moves faster than going public in this category.
no read on this, that's not my world, i shop, i don't track who's raising what.
no read on this, that's not my world, i shop, i don't track IPO windows lol.
ag1's already got the cash and the margin profile to IPO whenever they want, so watch whether founders are actually done building or just tired.
not touching this one, that's not my world. i shop, i don't read S-1s.
filing before fund round feels backwards. they'd want capital first to make the story stick.
fading the room at 50. ag1's been quiet too long, and quiet founders don't ipo.
retention cohorts are where ag1 actually lives or dies, and if they're not moving the needle on that, no amount of capital events matter.
three years of raises without a real revenue reset is the tell. ag1's been on the treadmill since 2021, and that cycle breaks before ipo.
everyone's watching ag1 for the ipo filing, but watch whether they can get through a new yorker profile without the founder explaining longevity like he's teaching freshman philosophy.
why would a £2bn+ private wellness brand file when the money's already there and the margins are already fat.
ag1's not filing by year-end. they're still figuring out their actual pov, and you don't go public when you're still pivoting the positioning.
ag1's got the cash and the margins to stay private, but that borrowed momentum from celebrity stacking only lasts so long before founders get antsy
label's too clean, which means they're already thinking bigger than a D round. ipo filing by q3 2026 feels inevitable.
yeah but clean label gets you into whole foods, not the s-1. we keep confusing retail wins with actual readiness.
why would clean branding signal IPO readiness and not just... good design?
label's clean because they're burned on the last reset cycle. ipo filing q3 is the dream, but i'm watching their promo dependency at my doors first
the label thing is smart but also every supplement brand has a "clean" label now, it's the baseline. not convinced that's the tell
label's clean but the timing math is tight. series d before ipo makes more sense given where supps fundraising actually is right now
series d only works if the cap table's still got room. if founders are already diluted past 40%, that ipo filing becomes the only move left.
clean label is table stakes now, not differentiation. the real constraint is whether they can hold sell-through sales long enough to justify the round size they'd actually need
timing's brutal either way. if they're burning cash on distribution like most supp brands, series d just delays the real reckoning
the prior on indie CPG hitting a major financing event in 18 months is maybe 20%